These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21848413)

  • 41. A study investigating obstetricians' and gynaecologists' management of women requesting an intrauterine device.
    Black KI; Sakhaei T; Garland SM
    Aust N Z J Obstet Gynaecol; 2010 Apr; 50(2):184-8. PubMed ID: 20522078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
    Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
    J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrauterine steroid contraceptives.
    Scholten PC; Christaens GC; Haspels AA
    Wien Med Wochenschr; 1987 Nov; 137(20-21):479-83. PubMed ID: 3131966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
    Boutet G
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Women's satisfaction with Norplant as compared with oral contraceptives.
    Eilers GM; Swanson TK
    J Fam Pract; 1994 Jun; 38(6):596-600. PubMed ID: 8195734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of combined endometrial resection or ablation and levonorgestrel intrauterine device on postoperative bleeding pattern.
    Heinemeier IIK; Messerschmidt L; Kragsig Thomsen T; Bertelsen PK; Rudnicki M
    Arch Gynecol Obstet; 2023 Feb; 307(2):493-499. PubMed ID: 36129518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bleeding patterns for the Liletta
    Schreiber CA; Teal SB; Blumenthal PD; Keder LM; Olariu AI; Creinin MD
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):116-120. PubMed ID: 29560743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bleeding Patterns among Adolescents Using the Levonorgestrel Intrauterine Device: A Single Institution Review.
    Parks MA; Zwayne N; Temkit M
    J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):555-558. PubMed ID: 32376363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body Mass Index and Levonorgestrel Device Expulsion in Adolescents and Young Adults.
    Masten M; Yi H; Beaty L; Hutchens K; Alaniz V; Buyers E; Moore JM
    J Pediatr Adolesc Gynecol; 2024 Aug; 37(4):407-411. PubMed ID: 38462038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Schwartz BI; Bear B; Short VL; Kazak AE
    Obstet Gynecol; 2023 Apr; 141(4):748-755. PubMed ID: 36897186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrauterine Device Use in Adolescents With Disabilities.
    Schwartz BI; Alexander M; Breech LL
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32719107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Users' perspectives on bleeding patterns after two years of levonorgestrel-releasing intrauterine system use.
    Nascimento R; Bahamondes L; Hidalgo M; Perrotti M; Espejo-Arce X; Petta CA
    Drugs R D; 2002; 3(6):387-91. PubMed ID: 12516941
    [No Abstract]   [Full Text] [Related]  

  • 59. Mirena intrauterine system in the treatment of menstrual disorders: a survey of UK patients' experience, acceptability and satisfaction.
    Robinson R; China S; Bunkheila A; Powell M
    J Obstet Gynaecol; 2008 Oct; 28(7):728-31. PubMed ID: 19065370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and associating factors of sexual dysfunction in women who use intrauterine device (IUD) for contraception.
    Panchalee T; Wongwananuruk T; Augsuwatana S; Sirimai K; Tammakunto M; Neangton C; Bunsuk S; Inthawong J
    J Med Assoc Thai; 2014 Jan; 97(1):20-7. PubMed ID: 24701725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.